Erratum to: Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation.

IF 8.2 1区医学 Q1 HEMATOLOGY

Haematologica Pub Date : 2024-08-01 DOI:10.3324/haematol.2024.285845

Zachary D Epstein-Peterson, Esther Drill, Umut Aypar, Connie Lee Batlevi, Philip Caron, Ahmet Dogan, Pamela Drullinsky, John Gerecitano, Paul A Hamlin, Caleb Ho, Allison Jacob, Ashlee Joseph, Leana Laraque, Matthew J Matasar, Alison J Moskowitz, Craig H Moskowitz, Chelsea Mullins, Colette Owens, Gilles Salles, Heiko Schöder, David J Straus, Anas Younes, Andrew D Zelenetz, Anita Kumar

引用次数: 0

查看原文本刊更多论文

勘误：免疫化疗加来那度胺治疗伴有可测量残留疾病的高危套状细胞淋巴瘤的评估。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Haematologica 医学-血液学

CiteScore

14.10

自引率

2.00%

发文量

349

审稿时长

3-6 weeks

期刊介绍： Haematologica is a journal that publishes articles within the broad field of hematology. It reports on novel findings in basic, clinical, and translational research. Scope: The scope of the journal includes reporting novel research results that: Have a significant impact on understanding normal hematology or the development of hematological diseases. Are likely to bring important changes to the diagnosis or treatment of hematological diseases.